Latest Intensive insulinotherapy Stories
Latest data on ultra rapid acting insulin presented at the American Diabetes Association's 69th Scientific Sessions NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of...
Intensive insulin therapy significantly increases the risk of hypoglycemia in critically ill patients, found a new study in CMAJ
Using an insulin pump to manage diabetes is assumed to be more convenient than daily injections, but U.S. researchers are checking quality of life. Dr.
WORCESTER, Mass., Oct.
AUSTIN, Texas, Sept. 17 /PRNewswire/ -- In a clinical trial comparing the i-port(R) (a small, disposable injection port about the size of a quarter) with standard injections in people with type 1 and type 2 diabetes, participants' differences in glycosylated albumin was not significantly different.
Generex Biotechnology has reached the enrollment milestone of more than 200 subjects in the company's pivotal Phase III clinical trial of Generex Oral-lyn, its proprietary prandial oral insulin spray product. The Phase III study will involve up to 750 subjects with Type-1 diabetes mellitus.
Generex Biotechnology has initiated dosing of over one hundred patients in the company's pivotal Phase III clinical trial of Generex Oral-lyn, its flagship proprietary oral insulin spray product.
By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - A new device that monitors blood sugar constantly and lets the patient pump insulin right away if needed might greatly simplify life for people with diabetes, experts told a meeting on Monday. The Medtronic Inc.
By David Douglas NEW YORK (Reuters Health) - Inhaled insulin offers patients with type 1 diabetes the potential of avoiding pre-meal injections -- without any loss of diabetes control, a study shows. "This can improve their quality of life, " Dr.